Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Hereditary angioedema type I (HAE1) is an autosomal dominant disorder caused by quantitative deficiency of the C1 esterase inhibitor (C1-INH), encoded by SERPING1, leading to recurrent angioedema (MONDO:0015053). Clinically, patients present with episodic subcutaneous and submucosal swelling, abdominal pain, and dizziness due to uncontrolled bradykinin release (PMID:22882460).
HAE1 follows autosomal dominant inheritance. Numerous heterozygous pathogenic variants in SERPING1 have been described. In a large Chinese family, the novel frameshift variant c.1391-1445del55 (p.Val464fsTer556) abolishing the stop codon in exon 8 segregated with low C1-INH and C4 levels in seven affected members (PMID:22882460). A de novo missense in exon 4 was reported in a sporadic patient with recurrent abdominal pain (PMID:27725554).
Multi-family studies further confirm genetic heterogeneity. A Colombian cluster includes four unrelated pedigrees with 79 affected individuals; segregation analysis in 44 members validated causative variants c.1417G>A (p.Val473Met), c.1420C>T (p.Tyr423Ter), and c.1238T>G (p.Met413Arg) (PMID:39724085). Czech national screening of 207 patients from 85 families detected causal variants in all but one family, highlighting a high prevalence of splicing defects.
The variant spectrum exceeds 900 unique alleles, encompassing missense, nonsense, frameshift, canonical splice-site, deep intronic, and large deletions. The recurrent nonsense c.1420C>T (p.Tyr423Ter) is reported across multiple populations. Segregation in extended pedigrees (44 individuals) confirms co-segregation with disease (PMID:39724085).
Functional assays demonstrate pathogenic mechanisms. Splice-site mutations c.51+3A>G and c.51+5G>A cause exon 2 skipping in minigene assays and cosegregate with low C1-INH levels (PMID:16470590). The deep intronic c.1029+384A>G activates a pseudoexon leading to nonsense-mediated decay (PMID:31982983). The p.Ser150Phe missense variant exerts dominant-negative effects by trapping wild-type C1-INH intracellularly (PMID:33914953). Recombinant expression of p.Pro399Ala and p.Cys130Trp variants shows impaired folding and secretion (PMID:36587848).
Collectively, genetic and experimental concordance across diverse cohorts establish a definitive association between SERPING1 and HAE1. Pathogenic variants disrupt C1-INH secretion or function via haploinsufficiency and dominant-negative effects, underpinning bradykinin-mediated angioedema. SERPING1 variant analysis is clinically actionable for diagnosis, family counseling, and personalized management in HAE1.
Gene–Disease AssociationDefinitiveOver 900 SERPING1 variants reported in hundreds of unrelated patients and extensive segregation in large families Genetic EvidenceStrongIdentification of >900 unique variants in heterozygous state across multiple large AD pedigrees; segregation confirmed in 44 individuals Functional EvidenceStrongConcordant functional studies (splicing assays, pseudoexon activation, in vitro expression, dominant-negative models) demonstrating loss of C1-INH secretion and activity |